Cite Filings / CPIX / 9999999995-23-003747

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

CUMBERLAND PHARMACEUTICALS INC Filed 2023-12-26 Acc 9999999995-23-003747

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2023-12-28 4 Director acquired 1,174 shares (code L)
2023-12-28 4 Director acquired 1,174 shares (code L)
2023-12-28 4 Director acquired 6,407 shares (code L)
2023-12-28 4 Chairman and CEO acquired 1,174 shares (code L)
2023-12-26 EFFECT Notice of Effectiveness
2023-12-21 CORRESP Correspondence Between Filers and SEC Staff
2021-01-08 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…